- Home
- PARA vs ROIV Comparison
PARA vs ROIV Comparison
Compare PARA & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PARA
- ROIV
- Stock Information
- Founded
- PARA 1986
- ROIV 2014
- Country
- PARA United States
- ROIV United Kingdom
- Employees
- PARA N/A
- ROIV N/A
- Industry
- PARA Broadcasting
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- PARA Industrials
- ROIV Health Care
- Exchange
- PARA Nasdaq
- ROIV Nasdaq
- Market Cap
- PARA 7.9B
- ROIV 8.4B
- IPO Year
- PARA N/A
- ROIV N/A
- Fundamental
- Price
- PARA $11.97
- ROIV $10.87
- Analyst Decision
- PARA Sell
- ROIV Buy
- Analyst Count
- PARA 14
- ROIV 4
- Target Price
- PARA $11.31
- ROIV $17.50
- AVG Volume (30 Days)
- PARA 6.9M
- ROIV 5.2M
- Earning Date
- PARA 05-08-2025
- ROIV 05-29-2025
- Dividend Yield
- PARA 1.67%
- ROIV N/A
- EPS Growth
- PARA N/A
- ROIV N/A
- EPS
- PARA N/A
- ROIV N/A
- Revenue
- PARA $28,720,000,000.00
- ROIV $122,585,000.00
- Revenue This Year
- PARA N/A
- ROIV N/A
- Revenue Next Year
- PARA $0.71
- ROIV N/A
- P/E Ratio
- PARA N/A
- ROIV N/A
- Revenue Growth
- PARA N/A
- ROIV 140.04
- 52 Week Low
- PARA $9.54
- ROIV $8.73
- 52 Week High
- PARA $13.05
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- PARA 59.30
- ROIV 51.00
- Support Level
- PARA $11.62
- ROIV $10.58
- Resistance Level
- PARA $12.03
- ROIV $11.07
- Average True Range (ATR)
- PARA 0.23
- ROIV 0.30
- MACD
- PARA 0.01
- ROIV -0.04
- Stochastic Oscillator
- PARA 87.76
- ROIV 30.21
About PARA Paramount Global Class B
Paramount Global operates in three global business segments: TV media, filmed entertainment, and direct to consumer. The TV media business includes television production studios and various broadcast and cable networks, including CBS, 15 owned CBS affiliates, Paramount, Nickelodeon, MTV, BET, and VH1. Filmed entertainment consists multiple film studios, most importantly Paramount Pictures. The film studios produce and distribute movies that they license to movie theaters and other media outlets. Direct to consumer includes the Paramount+, Pluto TV, and BET+ streaming services. Much of the content on Paramount's streaming platforms is created by the production studios housed within the firm's other two business segments.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.